Dexelvucitabine

From WikiMD.org
Jump to navigation Jump to search

Dexelvucitabine

Dexelvucitabine (pronunciation: dex-el-vu-ci-ta-bine) is a nucleoside reverse transcriptase inhibitor (NRTI) that was previously under investigation for the treatment of HIV and AIDS.

Etymology

The term "Dexelvucitabine" is derived from the chemical structure of the drug. The prefix "Dex-" refers to the dextrorotatory isomer, "-elvu-" is an abbreviation of the chemical name, and "-citabine" is a common suffix for cytidine analogues, which are a type of NRTI.

Mechanism of Action

Dexelvucitabine inhibits the action of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material. By blocking this enzyme, dexelvucitabine can help to reduce the amount of HIV in the body.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski